TransCode Therapeutics (RNAZ) Balance Sheet: Assets & Liabilities

TransCode Therapeutics (RNAZ) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), TransCode Therapeutics reported total assets of $162.40M and total liabilities of $152.06M. Shareholders' equity was $10.34M. Total debt stood at $0.00 against $17.81M in cash and short-term investments, a net cash position of $17.81M. That puts debt-to-equity at 0.00.

TransCode Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for TransCode Therapeutics, Inc. (RNAZ) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	17.81	5.81	2.77	2.77	4.97	20.83	20.83	0.83	0.20	0.21
Short-Term Investments	0.00	0.00	0.00	-	0.00	0.00	0.01	0.00	0.00	0.00
Cash & Short-Term Investments	17.81	5.81	2.77	2.77	4.97	20.83	20.84	0.83	0.20	0.21
Accounts Receivable	3.25	0.00	0.00	-	0.36	0.00	-	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Current Assets	0.92	0.83	1.69	1.69	2.05	1.91	1.91	0.00	0.00	0.00
Total Current Assets	21.98	7.09	4.46	4.46	7.38	22.73	22.73	0.83	0.20	0.21
Non-Current Assets
Property, Plant & Equipment (Net)	0.37	0.09	0.60	0.60	0.21	0.21	0.21	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	-	0.00	0.00	-	0.00	0.01	0.00
Goodwill	25.74	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Intangible Assets	114.30	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.11	0.11	0.11	0.00	-	-	0.22	0.00	0.00
Total Non-Current Assets	140.41	0.20	0.71	0.71	0.21	0.21	0.21	0.22	0.01	0.00
Total Assets	162.40	7.29	5.17	5.17	7.59	22.94	22.94	1.06	0.22	0.21
Current Liabilities
Accounts Payable	3.12	2.58	0.00	3.05	0.00	2.02	2.50	0.00	0.03	0.00
Short-Term Debt	0.00	0.04	0.41	-	0.00	0.00	-	0.00	0.00	0.04
Accrued Liabilities	3.49	2.71	-	3.05	4.35	-	2.50	0.40	-	-
Deferred Revenue	0.00	0.03	0.03	0.03	0.00	0.03	0.03	0.00	0.00	0.00
Other Current Liabilities	0.37	0.16	3.05	-	4.35	0.49	-	0.40	0.04	0.08
Total Current Liabilities	3.49	2.77	3.49	3.49	4.35	2.53	2.53	0.40	0.06	0.12
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.04	0.04	0.00	0.00	-	2.09	0.93	0.44
Deferred Tax Liabilities	0.23	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Liabilities	148.34	6.54	0.00	-	0.00	0.00	-	1.97	0.32	0.16
Total Non-Current Liabilities	148.57	6.54	0.04	0.04	0.00	0.00	-	4.06	1.25	0.60
Total Liabilities	152.06	9.31	3.53	3.53	4.35	2.53	2.53	4.46	1.31	0.72
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-97.86	-63.20	-46.42	-46.42	-27.87	-10.31	-10.31	-3.46	-1.12	-0.51
Accumulated Other Comprehensive Income	0.00	0.00	-	-	0.00	-	-	0.00	0.00	-0.01
Additional Paid-in Capital	108.20	61.18	48.06	48.06	31.11	30.71	30.71	0.05	0.02	0.02
Shares Outstanding	0.92	0.04	-	0.00	0.00	-	0.00	-	-	-
Total Stockholders' Equity	10.34	-2.02	1.64	1.64	3.24	20.40	20.40	-3.41	-1.10	-0.50
Total Liabilities & Equity	162.40	7.29	5.17	5.17	7.59	22.94	22.94	1.06	0.22	0.21

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TransCode Therapeutics Balance Sheet

How much debt does TransCode Therapeutics have?

TransCode Therapeutics had total debt of $0.00 as of Dec 31, 2025, against $17.81M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $38.29K a year earlier.

What are TransCode Therapeutics's total assets?

TransCode Therapeutics reported total assets of $162.40M as of Dec 31, 2025, up 2126.3% from $7.29M a year earlier. Total liabilities were $152.06M.

What is TransCode Therapeutics's shareholders' equity?

TransCode Therapeutics's shareholders' equity was $10.34M as of Dec 31, 2025, or about $11.27 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition